CPT 33510: Coronary Artery Bypass, Vein Graft, 1 Vessel
Medicare pays $1824 and commercial payers pay $2404 on average nationally for this procedure.
CPT code 33510 describes a surgical coronary artery bypass graft (CABG) procedure using a segment of vein (typically from the leg) to divert blood flow around a damaged coronary vessel to restore circulation, improve heart function, and reduce symptoms such as angina; service type: open cardiac surgery (coronary artery bypass, vein graft); typical site of service: inpatient hospital operating room / cardiac surgery suite.
For related coverage guidance, see recent payer policy updates: Surgical Site of Care - Hospital Outpatient, Dental Anesthesia Services, Dental Anesthesia Services.
Customize your policy alerts
Sign up for cpt 33510 policy alerts
Get alerted when payer policies referencing 33510 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
Commercial means sit above Medicare: Blue Cross Blue Shield averages $2,100, BUCA averages $2,403.90, Cigna averages $3,211, UnitedHealth Group averages $3,529, and Aetna and UnitedHealth Group present broader commercial variability versus Medicare’s mean of $1,824. Medicare’s mean of $1,824 is notably lower than BUCA’s average commercial mean of $2,403.90, indicating a substantial premium in average commercial reimbursement compared with the federal program. Dispersion (P75 minus P25) highlights how concentrated or variable payers are: Aetna’s spread is $1,825 ( $2,154.30 − $330.90 ), Blue Cross Blue Shield’s spread is $1,348.80 ( $2,665.30 − $1,316.50 ), BUCA’s spread is $1,673.40 ( $3,085.10 − $1,411.70 ), Cigna’s spread is $2,050.20 ( $4,034.40 − $1,984.20 ), and UnitedHealth Group’s spread is $2,120 ( $4,325.90 − $2,205.90 ). Medicare’s interquartile spread is $139 ( $1,890 − $1,751 ). The tightest interquartile concentration is Medicare at $139, while UnitedHealth Group and Cigna show the widest IQRs at $2,120 and $2,050.20 respectively, signaling the greatest mid-distribution variability among commercial payers.